What is Edronax used for?
What Is Reboxetine (Edronax) Used For? As the first selective norepinephrine (noradrenaline) reuptake inhibitor, reboxetine has been used in the treatment of depression, mainly acute depression and major depression and for maintenance for people who have responded well to using it.
What class of drug is Edronax?
Reboxetine, sold under the brand name Edronax among others, is a drug of the norepinephrine reuptake inhibitor (NRI) class, marketed as an antidepressant by Pfizer for use in the treatment of major depression, although it has also been used off-label for panic disorder and attention deficit hyperactivity disorder (ADHD …
Is reboxetine harmful?
Conclusions Reboxetine is, overall, an ineffective and potentially harmful antidepressant. Published evidence is affected by publication bias, underlining the urgent need for mandatory publication of trial data.
How do I quit Edronax?
Keep taking the tablets until your doctor tells you otherwise. Stopping suddenly can cause problems and your doctor may want you to reduce your dose gradually when this becomes necessary. You should expect that a normal course of treatment with reboxetine will last for around six months after your symptoms have eased.
Is reboxetine available in Australia?
Reboxetine (Edronax) is the latest addition to the choice of antidepressants available on the PBS in Australia. It is indicated for the treatment and prevention of relapse of major depression.
Does reboxetine increase dopamine?
Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
Can you overdose on Edronax?
In postmarketing experience, there have been few reports of overdose in patients taking reboxetine alone; none of these have proved fatal. Non-fatal overdoses in patients have been reported for patients taking up to 240 mg of reboxetine.
How does reboxetine make you feel?
Reboxetine may make you feel dizzy. If this happens, do not drive and do not use tools or machines until you feel better. Discuss any troublesome side-effects with your doctor.
Does reboxetine cause weight gain?
Reboxetine does not cause weight gain during routine clinical use and indeed has been advocated as an adjunctive treatment in the management of olanzapine-induced weight gain.
What is Edronax (reboxetine)?
INFORMATION ABOUT EDRONAX (reboxetine) | Depression.com.au AIM : This medication is intended to correct the chemical changes in your body, which are associated with depressive illness. This medication is different to Serotonin drugs (SSRIs).
What should I know about Edronax before taking it?
Some of the symptoms of an allergic reaction to Edronax may include: rash, itching or hives on the skin. Do not take Edronax if you are taking other medicines used to treat depression such as monoamine oxidase inhibitors (MAOIs). Do not take Edronax if you have glaucoma (high pressure in the eye).
What is the Edronax clinical program?
The initial Edronax clinical program consists of 15 phase II and III clinical trials that were conducted in adult (aged 18-65 years) and elderly (aged > 65 years) patients diagnosed with major depressive disorder (MDD).
How does Australia’s immigration system work?
Australia has a quite straightforward and point-based system for immigration and allocating permanent residency to skilled and talented people overseas. In the last few months, the Australian government has employed a few vital changes in the visa rules and process requirements, which will be applicable this year.